Cargando…
Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical Trials
IMPORTANCE: Molluscum contagiosum (MC) is a common viral skin infection that primarily affects children. Cantharidin, a topical vesicant, has a long history of use for MC in compounded formulations, but the safety and efficacy of doses, regimens, and application methods have not been demonstrated in...
Autores principales: | Eichenfield, Lawrence F., McFalda, Wendy, Brabec, Bradford, Siegfried, Elaine, Kwong, Pearl, McBride, Mark, Rieger, Jayson, Willson, Cynthia, Davidson, Matthew, Burnett, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7512131/ https://www.ncbi.nlm.nih.gov/pubmed/32965495 http://dx.doi.org/10.1001/jamadermatol.2020.3238 |
Ejemplares similares
-
Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum
por: Eichenfield, Lawrence F., et al.
Publicado: (2021) -
COVE-1: A Phase 2, Open-Label Study to Evaluate Efficacy and Safety and the Optimal Regimen of VP-102, a Proprietary Drug–Device Product Containing Topical Cantharidin (0.7% w/v) Under Occlusion for the Treatment of Common Warts
por: Guenthner, Scott, et al.
Publicado: (2021) -
Phase II, Double-Blind, Vehicle-Controlled Study to Determine the Cantharidin Dose Regimen, Efficacy, Safety, and Tolerability of VP-102 in Subjects with External Genital Warts
por: Guenthner, Scott, et al.
Publicado: (2021) -
Molluscum contagiosum
por: Rao, Kavita, et al.
Publicado: (2013) -
Molluscum Contagiosum
por: Low, R. Cranston
Publicado: (1946)